News

STEMCELL Technologies Signs Exclusive License with Propagenix to Commercialize EpiX™, an Innovation Empowering Epithelial Cell Biology and Cell Therapy STEMCELL Technologies has signed an exclusive license with Propagenix of Rockville, MD to commercialize its patented EpiX™ technology, a novel and revolutionary cell culture medium that enables unprecedented expansion of tissue-resident epithelial stem cells without any genetic manipulation

How the Global Talent Stream Can Improve Vancouver’s Biotechnology Sector With Canada's fast-growing tech sector facing a shortage of 220,000 workers by 2020, the federal government is right to expedite the immigration process for highly skilled workers with its new Global Talent Stream

Three Finalists Announced for the Inaugural Bloom Burton Award Annual award to recognize the most significant contributor to Canada's healthcare industry

Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies STEMCELL and CDI will work together on progressive solutions for the life science tools market

STEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells STEMCELL Technologies announces the development of CloneR™, a novel medium formulation to aid researchers in their ability to successfully genome edit human pluripotent stem cells

Dr. Allen Eaves of STEMCELL Technologies Inc. named EY Entrepreneur Of The Year™ Pacific 2016 Dr. Allen Eaves, Chairman, President and Chief Executive Officer of STEMCELL Technologies, a global biotechnology company that supplies tools and services to enable life science research, is this year's Entrepreneur Of The Year Pacific winner

STEMCELL Technologies Opens New Office and Laboratories in Cambridge, UK STEMCELL Technologies UK has recently celebrated the grand opening of their Cambridge-based facility

STEMCELL Technologies Signs Exclusive License Agreement with Cincinnati Children’s for Stem Cell-Derived Organoid Technology This agreement grants STEMCELL a license to novel methods for generating organoid models and to develop cell culture media and tools that would enable scientists to create organoids from PSCs in their own laboratories

GE Healthcare expands cell therapy portfolio with license of STEMCELL Technologies’ T-Cell reagents Exclusive licensing agreement will provide cGMP grade reagents to further enable development and manufacturing of cellular immunotherapies

Biocompare Review: EasySep™ Mouse CD4+ T Cell Enrichment Kit Provides Stress-Free Cell Isolation Read the latest Biocompare review of the EasySep™ Mouse CD4+ T Cell Enrichment Kit from STEMCELL Technologies

Now Available! Process Large Volumes of Blood, Leukapheresis Samples or PBMC with the Handheld Easy 50 Magnet STEMCELL TechnologiesTM is pleased to announce the release of our largest volume magnet yet, Easy 50 (Catalog #18002). Now up to 4 x 109 cells can be isolated in a single separation procedure

Now Available! Isolate Untouched Human Plasmacytoid Dendritic Cells (pDCs) with EasySep™ Human pDC Enrichment Kit (Catalog #19062) STEMCELL Technologies is delighted to announce the new release of EasySep™ Human pDC Enrichment Kit (Catalog #19062) , a new immunomagnetic, column-free method for the optimal recovery of purified human pDCs by negative selection